Sec Form 13G Filing - Nirland Limited filing for Conduit Pharmaceuticals Inc. (CDT) - 2025-02-20

Insider filing report for Changes in Beneficial Ownership

  • Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
  • Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox not checked   Rule 13d-1(b)
Checkbox checked   Rule 13d-1(c)
Checkbox not checked   Rule 13d-1(d)






SCHEDULE 13G




SCHEDULE 13G




SCHEDULE 13G




SCHEDULE 13G



Comment for Type of Reporting Person:  (1) Nirland Limited is wholly owned by Stockton Limited, a company registered in Guernsey ("Stockton Limited"), which is wholly owned by The Rowland Master Trust, a Guernsey trust ("The Rowland Master Trust"). Dovet Limited, a company registered in Guernsey ("Dovet Limited"), is the sole trustee of The Rowland Master Trust. By virtue of these relationships, each of Stockton Limited, The Rowland Master Trust and Dovet Limited may be deemed to share beneficial ownership of the securities held of record by Nirland Limited.


SCHEDULE 13G


 
Nirland Limited
 
Signature:/s/ David Rowland
Name/Title:David Rowland/Director
Date:02/20/2025
 
Stockton Limited
 
Signature:/s/ David Rowland
Name/Title:David Rowland/Director
Date:02/20/2025
 
The Rowland Master Trust
 
Signature:/s/ Barclay Rowland
Name/Title:Barclay Rowland/Director
Date:02/20/2025
 
Dovet Limited
 
Signature:/s/ Barclay Rowland
Name/Title:Barclay Rowland/Director
Date:02/20/2025
primary_doc.xml